Literature DB >> 31416952

Downgrading of regulation in regenerative medicine.

Douglas Sipp1,2,3,4, Margaret Sleeboom-Faulkner5.   

Abstract

Mesh：

Year:  2019        PMID： 31416952     DOI： 10.1126/science.aax6184

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  4 in total

Review 1.  New Models for the Evaluation of Specialized Medicinal Products: Beyond Conventional Health Technology Assessment and Pricing.

Authors:  Luca Pani; Karin Becker
Journal:  Clin Drug Investig       Date:  2021-05-20       Impact factor: 2.859

2.  The potent effects of Japan's stem-cell policies.

Authors:  David Cyranoski
Journal:  Nature       Date:  2019-09       Impact factor: 49.962

Review 3.  Unproven stem cell interventions: A global public health problem requiring global deliberation.

Authors:  Zubin Master; Kirstin R W Matthews; Mohamed Abou-El-Enein
Journal:  Stem Cell Reports       Date:  2021-06-08       Impact factor: 7.765

4.  ISSCR's Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventions.

Authors:  Leigh Turner
Journal:  Stem Cell Reports       Date:  2021-05-27       Impact factor: 7.765
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.